Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2026-05-05 @ 1:24 AM
Study NCT ID:
NCT04348032
Status:
UNKNOWN
Last Update Posted:
2022-03-31
First Post:
2020-04-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer
Sponsor:
Chinese Academy of Medical Sciences
Organization:
Organization Data
Organization:
Class:
UNKNOWN
Study ID:
2016YFC1303704
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |